Fluorine-18 (CAS 13981-56-1) Market Research Report 2017 – Healthcare, Healthcare Services, Nuclear Medicine and Radiopharmacology, Therapeutic Area Industries

The Fluorine-18 (CAS 13981-56-1) Market Research Report 2017 Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Nuclear Medicine and Radiopharmacology, Therapeutic Area Markets.

This Global Report 2017 is a result of industry experts’ diligent work on Researching the world market of Fluorine-18. The report helps to build up a clear view of the market (trends and prospects), identify major players in the industry, and estimate main downstream sectors.

The Fluorine-18 global market report 2017 key points:

– Fluorine-18 description, its application areas and related patterns
– Fluorine-18 market situation
– Fluorine-18 manufacturers and distributors
– Fluorine-18 prices (by region and provided by market players)
– Fluorine-18 end-uses breakdown
– Fluorine-18 downstream industries trends

The first chapter introduces the product by providing review of the most of its characteristics (composition, structure, hazards, storage, toxicological & ecological information, etc.).
The second chapter focuses on Fluorine-18 end-uses, the third one gives summary on a number of patents.
The fourth chapter deals with Fluorine-18 market trends review, distinguish Fluorine-18 manufacturers and suppliers.
Chapter 5 summarizes Fluorine-18 prices data.
The last chapter analyses Fluorine-18 downstream markets.

Please Note: The report is to be delivered 5 days after an order is placed.

Read more and order at Fluorine-18 (CAS 13981-56-1) Market Research Report 2017

Offices of Mental Health Practitioners South America Report – Healthcare, Healthcare Services, Mental Health, Therapeutic Area Industries

The Offices of Mental Health Practitioners South America Report Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Mental Health, Therapeutic Area Markets.

OFFICES OF MENTAL HEALTH PRACTITIONERS SOUTH AMERICA REPORT

The Offices of Mental Health Practitioners South America Report gives Market Consumption / Products / Services for 13 countries by 6 to 10-Digit NAICS Product Codes by 3 Time series: From 1997- 2016 and Forecasts 2017- 2024 & 2024-2028.

Countries covered include: Argentina, Bolivia, Brazil, Chile, Colombia, Ecuador, French Guiana, Guyana, Paraguay, Peru, Suriname, Uruguay, Venezuela

59 MARKET RESEARCH CHAPTERS. SPREADSHEET CHAPTERS: Market Consumption – in US$ by Country by Product/Service by Year. Market, Financial, Competitive, Market Segmentation, Industry, Critical Parameters, Marketing Costs Markets, Decision Makers, Performance, Product Launch.
SOUTH AMERICA & NATIONAL REPORT MARKET DATABASE & SPREADSHEETS. FINANCIAL SPREADSHEETS & DATABASES. INDUSTRY SPREADSHEETS & DATABASES.

Data includes Market Consumption by individual Product / Service, Per-Capita Consumption, Marketing Costs & Margins, Product Launch Data, Buyers, End Users & Customer Profile, Consumer Demographics. Historic Balance Sheets, Forecast Financial Data, Industry Profile, National Data.

The report is on a DVD containing the entire web and databases, or it is available online. Merge text, tables & databases for your own reports, spreadsheet calculations & modeling.

All significant Products/ Markets covered, 1903 pages, 4033 spreadsheets, 4037 database tables, 293 illustrations. Updated monthly. 12 month After-Sales Service. This database covers NAICS code: 62133.

Read more and order at Offices of Mental Health Practitioners South America Report

Minimally Invasive Pediatric Urologic Surgery, An Issue of Urologic Clinics. The Clinics: Internal Medicine 42-1 – Healthcare, Healthcare Services, Pediatrics, Therapeutic Area Industries

The Minimally Invasive Pediatric Urologic Surgery, An Issue of Urologic Clinics. The Clinics: Internal Medicine 42-1 Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Pediatrics, Therapeutic Area Markets.

Urologists were early adaptors of robotic assisted laparoscopy, and pediatric urology similarly led in incorporating the technology into the surgical armamentarium for treating even the smallest infants.  And it is in that tradition that this issue of Urologic Clinics of North America surveys the journey from the earliest pure laparoscopic procedures to the most advanced reconstruction possible today due to evolutions in technology. The issue begins with the procedure that arguably popularized the laparoscopic approach in pediatric urology-the laparoscopic orchiopexy, then posit the continued relevance of pure laparoscopy in the robotic era, before finally surveying contemporary advances in robotic-assisted pediatric urologic surgery. The issue is of relevance not only tor the novice contemplating a transition to laparoscopy or robotics but also for the seasoned minimally invasive surgeon seeking to enhance skills and augment his or her practice.

Read more and order at Minimally Invasive Pediatric Urologic Surgery, An Issue of Urologic Clinics. The Clinics: Internal Medicine 42-1

Genetic Predisposition to Cancer, An Issue of Hematology/Oncology Clinics of North America. The Clinics: Internal Medicine 24-5 – Healthcare, Healthcare Services, Oncology, Therapeutic Area Industries

The Genetic Predisposition to Cancer, An Issue of Hematology/Oncology Clinics of North America. The Clinics: Internal Medicine 24-5 Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Oncology, Therapeutic Area Markets.

This issue serves as a timely review of both the genetic and genomic factors resulting in a predisposition to human cancer.  There is now strong evidence to support the use of genetic testing for cancer predisposition in the practice of preventive medicine, and at the same time, there is emerging new literature defining the role of genomic approaches to assessment of cancer predisposition.  Articles address predisposition syndromes in the areas of breast cancer, lower GI cancer, genitourinary cancer, pediatric cancer, endocrine cancer, and hematologic malignancy.

Read more and order at Genetic Predisposition to Cancer, An Issue of Hematology/Oncology Clinics of North America. The Clinics: Internal Medicine 24-5

Practical Approach to Pediatric Gastroenterology, Hepatology and Nutrition – Gastroenterology, Healthcare, Healthcare Services, Therapeutic Area Industries

The Practical Approach to Pediatric Gastroenterology, Hepatology and Nutrition Report has been published. It provides updated in 2018 year analysis of industries from Gastroenterology, Healthcare, Healthcare Services, Therapeutic Area Markets.

Practical, handy and succinct, this full colour pocketbook provides clear–cut clinical guidance to the main symptoms that infants and children commonly present with in both primary and secondary care.

Clearly divided into specific sections covering the GI tract, liver and nutrition, Professor Kelly and her team discuss how best to investigate and manage specific clinical problems such as vomiting, abdominal pain, acute diarrhoea, constipation and jaundice using a highly clinical problem–orientated approach. 

 They cover the management of important clinical problems such as chronic liver disease, ascites, malnutrition, obesity, coeliac disease and inflammatory bowel disease, and provide advice on nutritional problems in premature infants and children including weaning and food aversion.

Key points, potential pitfalls, and management algorithms allow for rapid–reference, and link with the latest evidence, guidelines and protocols from ESPGHAN and NASPGHAN providing coverage of the major professional society recommendations for clinical practice.

Brought to you by the experts, Practical Approach to Gastroenterology, Hepatology and Nutrition is the perfect accompaniment for trainees in gastroenterology, hepatology and pediatrics, as well as nutritionists, GI nurses and GPs.

Read more and order at Practical Approach to Pediatric Gastroenterology, Hepatology and Nutrition

2017 Italy Hospital Hematology and Flow Cytometry Markets: Supplier Shares and Sales Segment Forecasts – Healthcare, Healthcare Services, Hematology, Therapeutic Area Industries

The 2017 Italy Hospital Hematology and Flow Cytometry Markets: Supplier Shares and Sales Segment Forecasts Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Hematology, Therapeutic Area Markets.

This new report contains 233 pages, 15 tables, and presents a comprehensive analysis of the Italian hospital hematology and flow cytometry markets, including:

– Major issues pertaining to the Italian hematology and flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.- Five-year volume and sales forecasts for major hematology and flow cytometry tests performed in Italian hospitals.- Annual placements and installed base estimates for major automated and semiautomated hematology analyzers and flow cytometers.- Review of current instrumentation technologies, and a feature comparison
of high-, medium-, and low-volume/POC analyzers.- Five-year reagent and instrument sales forecasts.- Sales and market shares of leading reagent and instrument suppliers.- Review of current and emerging technologies, and their potential market applications.- Product development opportunities for instruments, consumables, and auxiliary products.- Profiles of major current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R'D, collaborative arrangements, and business strategies.- Business opportunities and strategic recommendations for suppliers.

Contains 233 pages and 15 tables

Read more and order at 2017 Italy Hospital Hematology and Flow Cytometry Markets: Supplier Shares and Sales Segment Forecasts

Pancreatic Cancer: Current Concepts in Treatment and Research, An Issue of Surgical Oncology Clinics. The Clinics: Surgery 19-2 – Healthcare, Healthcare Services, Oncology, Therapeutic Area Industries

The Pancreatic Cancer: Current Concepts in Treatment and Research, An Issue of Surgical Oncology Clinics. The Clinics: Surgery 19-2 Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Oncology, Therapeutic Area Markets.

This issue of the Surgical Oncology Clinics will cover the following topics: imaging for pancreatic cancer, EUS staging and novel therapeutics for pancreatic cancer, management of cystic tumors, management of IPMN, laparoscopic surgery for pancreatic tumors, current concepts in the surgical management of pancreatic cancer, management of borderline resectable pancreatic cancer, regionalization of pancreatic surgery, update on adjuvant trials for pancreatic cancer, neoadjuvant therapy for pancreatic cancer, novel targets for pancreatic cancer therapy, and new frontiers in pancreatic cancer.

Read more and order at Pancreatic Cancer: Current Concepts in Treatment and Research, An Issue of Surgical Oncology Clinics. The Clinics: Surgery 19-2

Asian Dermatology Devices Market by Type, by End User – Forecast to 2019 – Dermatology, Healthcare, Healthcare Services, Therapeutic Area Industries

The Asian Dermatology Devices Market by Type, by End User – Forecast to 2019 Report has been published. It provides updated in 2018 year analysis of industries from Dermatology, Healthcare, Healthcare Services, Therapeutic Area Markets.

Asian Dermatology Devices Market by Type (Dermatology Treatment Devices, Dermatology Diagnostic Devices), by End User (Hospitals, Clinics) – Forecast to 2019

The Asian Dermatology Devices market is estimated to grow at a CAGR of 11.3% from 2014 to 2019. China holds a larger share in the Dermatology devices market around 28.8% in 2014 followed by Japan. The Asian Dermatology Devices market holds a high potential for growth in future due to a number of forces favoring this market. These include increasing number of people suffering from skin disorders, demand for devices at a lower cost and increasing awareness aesthetic procedures. However, price sensitive market is having an adverse effect on the dermatology devices market.

In this report, the Asian Dermatology devices market is broadly classified on the basis of product types, end users. The products segment is classified into Dermatology treatment devices and Dermatology diagnostic devices. Based on end users, the Dermatology devices market is categorized into Hospitals and Clinics.

Geographically the market is divided into eight countries, namely Japan, China, India, Korea, Singapore, Malaysia, Indonesia and Rest of Asia (RoE). China is estimated to command the largest share of 28.7% of the Asian Dermatology Devices market in 2014, followed by Japan. Japan is estimated to grow at a CAGR of 7.9% during the forecast period from 2014 to 2019.

Certain factors that influence the demand for the Asian dermatology devices market include the increasing number of people who suffer from skin disorders and the demand for devices at a lower cost. Thus, world-class manufacturers are coming up with devices at a lower price and concentrate on the Asian region to expand their business and geographical reach. Countries in the Asian region, namely India and China have a tropical climate, making the inhabitants of this region extremely prone to sun exposure, particularly skin tanning. Thus, there is an increase in the demand for dermatological treatments that have an impact on the growth of the dermatology diagnostic devices market in Asia. The number of skin cancer cases in Singapore has been increasing. There were 2,819 cases of skin cancer in Singapore from 2008 to 2012, among which 83.0% were Chinese, according to the National Skin Centre, followed by Malays recording 4.5% of the cases.

The report has profiled the leading players of this market along with the developments (New product launches and partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years and strategies adopted by them to sustain and strengthen their position in the Asian Dermatology Devices market. Heine Optotechnik (Germany), Optomed Oy (Finland), FotoFinder Systems (Germany), Michelson diagnostics (UK), Genesis Biosystems (U.S.), Ellipse A/S (Denmark), Alma Lasers (Israel), Palomar Technologies (U.S.), GE Healthcare (UK), and Philips Healthcare (Netherlands), HEINE Optotechnik (Germany), 3Gen LLC (U.S.), Welch Allyn (U.S.), Carl Zeiss Meditec, Inc. (U.S.), Hitachi (Japan), Leica Microsystems (Germany), Olympus (Japan), GE Healthcare (U.K.), Phillips Healthcare (Netherlands), Toshiba Medical Systems (Japan), and Siemens Medical Systems (Germany). are some of the key players engaged in this market.

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis—industry analysis (industry trends, and PEST analysis), market share analysis of top players, supply chain analysis, and company profiles, which together comprise and discuss the basic views on the competitive landscape, usage patterns, emerging- and high-growth segments of the Asian Dermatology Devices market, high-growth regions and countries and their respective regulatory policies, government initiatives, drivers, restraints, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help the firms in garnering a greater market, share. Firms purchasing the report could use any one or combination of the below mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market share.

The report provides insights on the following pointers:

Supply Chain Analysis:
– Eminent players providing dermatology devices, original equipment manufacturers (OEMs), distributors, and end customers (hospitals and clinics) are the key stakeholders in the supply chain. The dermatologists, physicians, practitioners, caregivers, researchers and scientists, investors/funders, and regulatory bodies are major influencers.
– The eminent players are basically the well-established and financially viable entities operating in the market for a very long time and have carved a niche for themselves across the market.
– They have a potential hold over the market generating an enhanced bottom line by maintaining a diversified product mix, sound geographical expansion, extensive distribution network, and high economies of scale. Certain matured companies in this market include Nikon Corporation (Japan), Olympus Corporation (Japan), Carl Zeiss (U.S.), Alma Lasers Ltd (Israel), and Lumenis (Israel).

Impact Analysis: Impact of increasing incidence of skin disorders like melanoma of skin, psoriasis on the demand for dermatology devices (diagnostic and treatment devices). Impact of demand of aesthetic beautification.

Read more and order at Asian Dermatology Devices Market by Type, by End User – Forecast to 2019

Endometriosis – Market Insights, Epidemiology and Market Forecast – 2025 – Healthcare, Healthcare Services, Therapeutic Area, Women’s Health Industries

The Endometriosis – Market Insights, Epidemiology and Market Forecast – 2025 Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Therapeutic Area, Women’s Health Markets.

Endometriosis – Market Insights, Epidemiology and Market Forecast – 2025 provides an overview of the disease and in depth research related to Endometriosis for the 7MM (United States, Germany, France, Italy, Spain and UK) for the study period undertaken from 2015-2025. This report provides understanding of the patients affected, diagnosed patterns, treatment trends, unmet medical needs and current developments for Endometriosis . It enables understanding of the historical and forecasted epidemiological data for the diagnosed prevalent cases of Endometriosis for 7 major markets.

The market outlook also provides understanding of country specific revenue and share by analyzing performance of the current therapies and thorough potential uptake of new products. Additionally, the report highlights the frontrunners, the drivers and barriers for the Endometriosis market, as well as treatment algorithm, current treatments & advancements are included. The chapters including marketed products highlights the advantages and disadvantages associated with therapies associated with Endometriosis, providing an in-depth analysis of emerging therapies which will create an impact through their launch.

According to research, the forecasted patient population of Endometriosis for the year 2025 will be XX, increasing at a CAGR of XX% from 2015 to 2025 and the Endometriosis 7MM market size is estimated to be USD XX by 2025. The report will help in enhanced understanding of the Endometriosis market from inside out, with transparency into the calculated patient forecasting data and estimated market size.

Key Coverage:

  • Understanding historical and forecasted epidemiological data for Endometriosis covering 7MM from 2015-2025.
  • Segment level epidemiology and market split for Endometriosis .
  • The thorough assessment of competitors, market, current trends & treatments along with upcoming treatments for Endometriosis .
  • The report also covers the market size for 7MM (United States, EU 5 (Germany, Spain, Italy, France and United Kingdom) and Japan) from 2015-2025 and detailed historical and forecasted Endometriosis market trends.
  • Thorough market distribution based on market share for Endometriosis .

Reasons to Buy:

  • The report will help in developing business strategies by understanding trends shaping and driving the Endometriosis market.
  • To understand the future market competition in the Endometriosis market and Insightful review of the key market drivers and barriers.
  • Organize sales and marketing efforts by identifying the best opportunities for Endometriosis in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan.
  • Identification of strong upcoming players in market will help in devising strategies that will help in getting ahead of competitors.

Note: Please allow up to 24 hours for delivery after payment has been made.

Read more and order at Endometriosis – Market Insights, Epidemiology and Market Forecast – 2025

2016-2020 U.K. Hematology and Flow Cytometry Markets: Instrument and Reagent Supplier Shares, Volume and Sales Country Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities – Healthcare, Healthcare Services, Hematology, Therapeutic Area Industries

The 2016-2020 U.K. Hematology and Flow Cytometry Markets: Instrument and Reagent Supplier Shares, Volume and Sales Country Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities Report has been published. It provides updated in 2018 year analysis of industries from Healthcare, Healthcare Services, Hematology, Therapeutic Area Markets.

This new study is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the U.K. hematology and flow cytometry markets during the next five years.

The report explores business and technological trends in the U.K. market; provides market share estimates, as well as specimen, test, sales forecasts, and instrument placements; compares features of major analyzers; profiles leading competitors and emerging market entrants; and suggests specific product and marketing opportunities facing reagent and instrument suppliers.

Rationale

During the next five years, continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, autocalibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.

UK Market Overview

– Facilities performing hematology and flow cytometry testing.
– Test volume and sales projections.

Strategic Recommendations

– New product development opportunities with significant market appeal.
– Alternative market penetration strategies.
– Potential market entry barriers and risks.

Market Segmentation Analysis

– Sales and market share estimates for leading suppliers of hematology and flow cytometry products by country.

– Specimen, test and sales forecasts for over 40 procedures by individual test and market segment:
– Hospitals
– Commercial/Private Laboratories
– Ambulatory Care Centers

Sales and Market Share Analysis

– Sales and market shares of major instrument and reagent suppliers.

Hematology Tests

CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils.

Flow Cytometry Tests

Cell Surface Markers (CD4/CD8/T&B Lymphocytes, CD34, Others), Chemotherapy Monitoring (Leukemia/Lymphoma, Others), HLA Typing, Sperm Analysis, Cell Cycle Kinetics, Cell Function Testing, Chromosomal Abnormalities, Fetal Cell Analysis, Granulocyte Function, Receptor DNA/RNA Analysis, Cell Culturing.

Current and Emerging Products

– Analysis of current and emerging hematology and flow cytometry assays.
– Reagent and instrument sales forecasts by market segment.
– Instrument placements and installed base by manufacturer and model.
– Sales and market shares of reagent and instrument suppliers.

Instrumentation Review

– The study reviews current instrumentation technologies, and compares features of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers.

– The report features analyzers manufactured by Abbott, Beckman Coulter/Danaher, Becton Dickinson, Biocode Hycel, CellaVision, Diesse Ves Matic, Drew-Scientific, Horiba, Medica, Menarini, Nihon Kohden, Polymedco, Siemens and Sysmex.

Technology Review

– Assessment of current and emerging technologies and their potential market applications.

– Comprehensive lists of companies developing or marketing new technologies and products by test.

Competitive Assessments

– Extensive strategic profiles of major suppliers and emerging market entrants.

– The companies analyzed in the report include:

– Abbott
– Agilent Technologies
– Beckman Coulter/Danaher
– Becton Dickinson
– Bio-Rad
– CellaVision
– Horiba
– Iris Diagnostics/Danaher
– Nihon Kohden
– Ortho-Clinical Diagnostics
– Roche
– Siemens
– Sysmex

Contains 250 pages and 30 tables

Read more and order at 2016-2020 U.K. Hematology and Flow Cytometry Markets: Instrument and Reagent Supplier Shares, Volume and Sales Country Segment Forecasts, Innovative Technologies, Instrumentation Review, Competitive Strategies, Emerging Opportunities